Coincidentally, Maffei and colleagues found that plasma glutathione S-transferase activity in CRC patients was comparable with the healthy controls and patients with adenomas, however, plasma catalase, glutathione reductase, superoxide dismutase, and clastogenic factors were significantly changed, either decreased or increased, in patients with CRC [50]. This evidence concerns the gene CAT and colorectal carcinoma.